Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma.

Kristen M WeishaarZachary M WrightMona P RosenbergGerald S PostJennifer A McDanielCraig A CliffordBrenda S PhillipsPhilip J BergmanElissa K RandallAnne C AveryDouglas H ThammAbigail A Christman HullCathy M GustAnn R Donoghue

Published in: Journal of veterinary internal medicine (2021)

Rabacfosadine demonstrated statistically significant antitumor efficacy in dogs with lymphoma when administered every 21 days for up to 5 treatments as compared to placebo.

Keyphrases

double blind
placebo controlled
diffuse large b cell lymphoma
clinical trial
phase iii
phase ii
study protocol
open label
randomized controlled trial
cross sectional